Carl Hansen
Carl Hansen is the Chief Executive Officer of AbCellera Biologics Inc., a Canada-based biotech company. He has voiced concerns that significant reductions in U.S. drug spending, as proposed by recent executive orders, could devastate the pharmaceutical industry unless other countries compensate for the loss. Hansen emphasizes the importance of high prices for successful drug development to account for the costs associated with bringing new medications to market.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 6.00 | 0.05% | +0% | 331,002,651 | 162,177 | $21,000,000 | 10,289$ |
| Totals | 1 | 331,002,651 | 162,177 | $21,000,000 | 10,289$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Carl Hansen, vice president and head of government relations at Coco Robotics, commented on the incident involving the robot.
6
Canada:
Carl Hansen is the chief executive of AbCellera.
7
Canada:
Carl Hansen, CEO of Canada-based biotech company AbCellera Biologics Inc., said a dramatic drop in how much the U.S. spends on drugs could be devastating to the pharmaceutical industry.
5